OnKure Therapeutics, Inc. (OKUR)
NASDAQ: OKUR · Real-Time Price · USD
4.060
-0.080 (-1.93%)
Aug 10, 2026, 4:00 PM EDT - Market closed
OnKure Therapeutics Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, OnKure Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $19.5. The average 1-year stock price forecast is 380.30% higher than the current stock price, while the lowest is $11 (+170.94%) and the highest is $30 (+638.92%).
Price Target: $19.5 (+380.30%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for OnKure Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 5 | 5 | 5 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| LifeSci Capital | LifeSci Capital | Buy Maintains $16 | Buy | Maintains | $16 | +294.09% | Aug 6, 2026 |
| JonesTrading | JonesTrading | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 5, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $27 → $21 | Buy | Reiterates | $27 → $21 | +417.24% | Jul 20, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $30 | Buy | Maintains | $30 | +638.92% | Jun 24, 2026 |
Financial Forecast
Revenue This Year
500.00K
Revenue Next Year
1.00M
from 500.00K
Increased by 100.00%
EPS This Year
-1.96
from -4.40
EPS Next Year
-1.96
from -1.96
EPS and Forward PE are based on non-GAAP adjusted numbers.